Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility.
J Med Chem
; 66(13): 8929-8950, 2023 07 13.
Article
in En
| MEDLINE
| ID: mdl-37314941
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Janus Kinase Inhibitors
Limits:
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2023
Type:
Article
Affiliation country:
United States